Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold

Biomedical Materials

Volumn 3, Issue 1, 2008, Pages

  Laflamme, Claude ^a   Rouabhia, Mahmoud ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CARRIER PROTEIN; COLLAGEN; GELATINASE A; GELATINASE B; HOMODIMER; INTERLEUKIN 6; MESSENGER RNA; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; BONE MORPHOGENETIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE REGENERATION; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; MEASUREMENT; OSTEOBLAST; PROTEIN SECRETION; UPREGULATION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DIMERIZATION; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; MATERIALS TESTING; METHODOLOGY; PHYSIOLOGY; TISSUE ENGINEERING;

BONE MORPHOGENETIC PROTEINS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; COLLAGEN; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; MATERIALS TESTING; OSTEOBLASTS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 40549141414     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/3/1/015008     Document Type: Article

References (45)

1. Boyne P J 2001 Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects J. Bone Joint Surg. Am. 83A S146-50
2. Geiger M, Li R H and Friess W 2003 Collagen sponges for bone regeneration with rhBMP-2 Adv. Drug Deliv. Rev. 55 1613-29
3. Carlisle E and Fischgrund J S 2005 Bone morphogenetic proteins for spinal fusion Spine J. 5 S240-9
4. Kenley R A, Yim K, Abrams J, Ron E, Turek T, Marden L J and Hollinger J O 1993 Biotechnology and bone graft substitutes Pharm. Res 10 1393-401
5. Hollinger J O, Uludag J O and Winn S R 1998 Sustained release emphasizing recombinant human bone morphogenetic protein-2 Adv. Drug Deliv. Rev. 31 303-18
6. Artico M, Ferrante L, Pastore F S, Ramundo E O, Cantarelli D, Scopelliti D and Iannetti G 2003 Bone autografting of the calvaria and craniofacial skeleton: historical background, surgical results in a series of 15 patients, and review of the literature Surg. Neurol 60 71-9
7. Giannoudis P V, Dinopoulos H and Tsiridis E 2005 Bone substitutes: an update Injury 36 (Suppl. 3) S20-7
8. Eppley B L, Pietrzak W S and Blanton M W 2005 Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon J. Craniofac. Surg. 16 981-9
9. Dimitriou R and Giannoudis P V 2005 Discovery and development of BMPs Injury 36 (Suppl. 3) S28-33
10. Groeneveld E H and Burger E H 2000 Bone morphogenetic proteins in human bone regeneration Eur. J. Endocrinol. 142 9-21
11. Nakagawa T and Tagawa T 2000 Ultrastructural study of direct bone formation induced by BMPs-collagen complex implanted into an ectopic site Oral Dis. 6 172-9
12. Kato M, Toyoda H, Namikawa T, Hoshino M, Terai H, Miyamoto S and Takaoka K 2006 Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2) Biomaterials 27 2035-41
13. Israel D I, Nove J, Kerns K M, Kaufman R J, Rosen V, Cox K A and Wozney J M 1996 Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo Growth Factors 13 291-300
14. Zhu W, Rawlins B A, Boachie-Adjei O, Myers E R, Arimizu J, Choi E, Lieberman J R, Crystal R G and Hidaka C 2004 Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model J. Bone Miner. Res. 19 2021-32
15. Bostrom M P, Lane J M, Berberian W S, Missri A A, Tomin E, Weiland A, Doty S B, Glaser D and Rosen V M 1995 Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing J. Orthop. Res. 13 357-67
16. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath T K, ten Dijke P and Sakou T 1998 Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats Bone 22 605-12
17. Mayer H, Scutt A M and Ankenbauer T 1996 Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins -2 to -7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor Calcif. Tissue Int. 58 249-55
18. Hogan B L 1996 Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10 1580-94
19. Kang Q et al 2004 Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery Gene Ther. 11 1312-20
20. Peng Y, Kang Q, Cheng H, Li X, Sun M H, Jiang W, Luu H H, Park J Y, Haydon R C and He T C 2003 Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signalling J. Cell. Biochem. 90 1149-65
21. de Jong D S, Vaes B L, Dechering K J, Feijen A, Hendriks J M, Wehrens R, Mummery C L, van Zoelen E J, Olijve W and Steegenga W T 2004 Identification of novel regulators associated with early-phase osteoblast differentiation J. Bone Miner. Res. 19 947-58
22. Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S and Fujisawa Y 1995 Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer Biochem. Biophys. Res. Commun. 210 670-7
23. Lyons K M, Hogan B L and Robertson E J 1995 Colocalization of BMP-7 and BMP-2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development Mech. Dev. 50 71-83
24. Suzuki Y, Tanihara M, Suzuki K, Saitou A, Sufan W and Nishimura Y 2000 Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo J. Biomed. Mater. Res. 50 405-9
25. Giannoudis P V and Tzioupis C 2005 Clinical applications of BMP-7: the UK perspective Injury 36 (Suppl. 3) S47-50
26. Brown A, Stock G, Patel A A, Okafor C and Vaccaro A 2006 Osteogenic protein-1: a review of its utility in spinal applications Biodrugs 20 243-51
27. Saito N and Takaoka K 2003 New synthetic biodegradable polymers as BMP carriers for bone tissue engineering Biomaterials 24 2287-93
28. Liu H W, Chen C H, Tsai C L and Hsiue G H 2006 Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation Bone 39 825-36
29. Denizot F and Lang R 1986 Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability J. Immunol. Methods 89 271-7
30. Tardif F, Ross G and Rouabhia M 2004 Gingival and dermal fibroblasts produce interleukin-1 beta converting enzyme and interleukin-1 beta but not interleukin-18 even after stimulation with lipopolysaccharide J. Cell. Physiol. 198 125-32
31. Mostefaoui Y, Bart C, Frenette M and Rouabhia M 2004 Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells Cell. Microbiol. 6 1085-96
32. Claveau I, Mostefaoui Y and Rouabhia M 2004 Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans Matrix Biol. 23 477-86
33. Rouabhia M, Ross G, Page N and Chakir J 2002 Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation Infect. Immun. 70 7073-80
34. Desbois C and Karsenty G 1995 Osteocalcin cluster: implications for functional studies J. Cell. Biochem. 57 379-83
35. Albrektsson T and Johansson C 2001 Osteoinduction, osteoconduction and osseointegration Eur. Spine J. 10 (Suppl. 2) S96-101
36. Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M and Miyazono K 2001 Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction J. Cell. Sci. 114 1483-9
37. Sampath T K, Coughlin J E, Whetstone R M, Banach D, Corbett C, Ridge R J, Ozkaynak E, Oppermann H and Rueger D C 1990 Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily J. Biol. Chem. 265 13198-205
38. Tsuji K, Ito Y and Noda M 1998 Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells Bone 22 87-92
39. Chen D, Harris M A, Rossini G, Dunstan C R, Dallas S L, Feng J Q, Mundy G R and Harris S E 1997 Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts Calcif. Tissue Int. 60 283-90
40. Manolagas S C 1998 The role of IL-6 type cytokines and their receptors in bone Ann. NY Acad. Sci. 840 194-204
41. Taguchi Y, Yamamoto M, Yamate T, Lin S C, Mocharla H, DeTogni P, Nakayama N, Boyce B F, Abe E and Manolagas S C 1998 Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage Proc. Assoc. Am. Physicians 110 559-74
42. Thies R S, Bauduy M, Ashton B A, Kurtzberg L, Wozney J M and Rosen V 1992 Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells Endocrinology 130 1318-24
43. Sternlicht M D and Werb Z 2001 How matrix metalloproteinases regulate cell behavior Annu. Rev. Cell Dev. Biol. 17 463-516
44. Gazzerro E, Rydziel S and Canalis E 1999 Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts Endocrinology 140 562-7
45. Varghese S and Canalis E 1997 Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures Endocrinology 138 1035-40